» Articles » PMID: 16119510

A Comparison of Placebo and No-treatment During a Hypnotic Clinical Trial

Overview
Specialty Pharmacology
Date 2005 Aug 27
PMID 16119510
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Sleep parameters commonly improve during placebo treatment in insomnia clinical trials. We examined whether the improvement seen with placebo was related to taking pills or other non-specific factors.

Method: 95 insomniacs took either a placebo pill (pill+) or no pill (pill-) on nights of their choosing over 12 weeks.

Results: Pills were consumed on about half of the nights. Consistent improvement was seen with reduced reported sleep latency, wakefulness after sleep onset, number of awakenings, and total sleep time over the 12 weeks for both the pill+ and pill condition. A difference between pill+ and pill- was detected only for total sleep time, and this difference favored pill+.

Conclusions: This study suggests that improvement seen during placebo treatment is more related to non-specific factors of participating in clinical trial than to pill taking behavior.

Citing Articles

Effects of electrostatic therapy on nighttime sleep and daytime symptoms in patients with chronic insomnia: Evidences from an open label study.

Dai Y, Qin Q, Chen B, Chen L, Sun Q, Vgontzas A Front Neurosci. 2023; 16:1047240.

PMID: 36685220 PMC: 9853294. DOI: 10.3389/fnins.2022.1047240.


Control interventions in randomised trials among people with mental health disorders.

Faltinsen E, Todorovac A, Bruun L, Hrobjartsson A, Gluud C, Kongerslev M Cochrane Database Syst Rev. 2022; 4:MR000050.

PMID: 35377466 PMC: 8979177. DOI: 10.1002/14651858.MR000050.pub2.


Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.

Winkler A, Rief W Sleep. 2014; 38(6):925-31.

PMID: 25515108 PMC: 4434559. DOI: 10.5665/sleep.4742.


The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.

Tek C, Palmese L, Krystal A, Srihari V, DeGeorge P, Reutenauer E Schizophr Res. 2014; 160(1-3):180-5.

PMID: 25454802 PMC: 5589464. DOI: 10.1016/j.schres.2014.10.002.


Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.

McCall W, DAgostino Jr R, Rosenquist P, Kimball J, Boggs N, Lasater B Sleep Med. 2011; 12(6):557-64.

PMID: 21601519 PMC: 3110560. DOI: 10.1016/j.sleep.2011.03.008.